Logo image of HLN

HALEON PLC-ADR (HLN) Stock Fundamental Analysis

NYSE:HLN - New York Stock Exchange, Inc. - US4055521003 - ADR

9.24  +0.05 (+0.54%)

After market: 9.14 -0.1 (-1.08%)

Fundamental Rating

4

HLN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. There are concerns on the financial health of HLN while its profitability can be described as average. HLN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year HLN was profitable.
In the past year HLN had a positive cash flow from operations.
In the past 5 years HLN has always been profitable.
In the past 5 years HLN always reported a positive cash flow from operatings.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

1.2 Ratios

HLN has a better Return On Assets (3.26%) than 63.89% of its industry peers.
Looking at the Return On Equity, with a value of 6.55%, HLN is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
HLN has a Return On Invested Capital (5.87%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for HLN is significantly below the industry average of 13.52%.
The 3 year average ROIC (5.38%) for HLN is below the current ROIC(5.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.26%
ROE 6.55%
ROIC 5.87%
ROA(3y)3.39%
ROA(5y)3.07%
ROE(3y)6.03%
ROE(5y)4.97%
ROIC(3y)5.38%
ROIC(5y)4.91%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2 4 6

1.3 Margins

The Profit Margin of HLN (9.66%) is better than 77.78% of its industry peers.
HLN's Profit Margin has declined in the last couple of years.
HLN has a Operating Margin of 21.13%. This is amongst the best in the industry. HLN outperforms 97.22% of its industry peers.
HLN's Operating Margin has been stable in the last couple of years.
HLN has a Gross Margin (61.56%) which is comparable to the rest of the industry.
HLN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.13%
PM (TTM) 9.66%
GM 61.56%
OM growth 3Y0.01%
OM growth 5YN/A
PM growth 3Y-7.1%
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HLN is destroying value.
The number of shares outstanding for HLN remains at a similar level compared to 1 year ago.
The debt/assets ratio for HLN has been reduced compared to a year ago.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

HLN has an Altman-Z score of 2.45. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN has a Altman-Z score of 2.45. This is comparable to the rest of the industry: HLN outperforms 52.78% of its industry peers.
HLN has a debt to FCF ratio of 4.69. This is a neutral value as HLN would need 4.69 years to pay back of all of its debts.
HLN's Debt to FCF ratio of 4.69 is fine compared to the rest of the industry. HLN outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that HLN is not too dependend on debt financing.
HLN has a worse Debt to Equity ratio (0.45) than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.69
Altman-Z 2.45
ROIC/WACC0.77
WACC7.65%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.84 indicates that HLN may have some problems paying its short term obligations.
With a Current ratio value of 0.84, HLN is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.58 indicates that HLN may have some problems paying its short term obligations.
HLN's Quick ratio of 0.58 is on the low side compared to the rest of the industry. HLN is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.58
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

HLN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.24%.
The Earnings Per Share has been decreasing by -1.91% on average over the past years.
The Revenue has decreased by -0.65% in the past year.
The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)-0.24%
EPS 3Y-1.91%
EPS 5YN/A
EPS Q2Q%-8.8%
Revenue 1Y (TTM)-0.65%
Revenue growth 3Y4.54%
Revenue growth 5YN/A
Sales Q2Q%-0.64%

3.2 Future

The Earnings Per Share is expected to grow by 8.34% on average over the next years. This is quite good.
HLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y8.62%
EPS Next 2Y8.84%
EPS Next 3Y8.88%
EPS Next 5Y8.34%
Revenue Next Year-0.41%
Revenue Next 2Y1%
Revenue Next 3Y2.25%
Revenue Next 5Y4.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.05 0.1 0.15 0.2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 54.35, which means the current valuation is very expensive for HLN.
Compared to the rest of the industry, the Price/Earnings ratio of HLN is on the same level as its industry peers.
HLN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.96.
HLN is valuated quite expensively with a Price/Forward Earnings ratio of 46.89.
HLN's Price/Forward Earnings is on the same level as the industry average.
HLN is valuated expensively when we compare the Price/Forward Earnings ratio to 24.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 54.35
Fwd PE 46.89
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

HLN's Enterprise Value to EBITDA is on the same level as the industry average.
75.00% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.14
EV/EBITDA 15.75
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
HLN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.3
PEG (5Y)N/A
EPS Next 2Y8.84%
EPS Next 3Y8.88%

3

5. Dividend

5.1 Amount

HLN has a Yearly Dividend Yield of 1.68%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.15, HLN pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.29, HLN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

HLN has been paying a dividend for over 5 years, so it has already some track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DPN/A
EPS Next 2Y8.84%
EPS Next 3Y8.88%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 500M 1B 1.5B

HALEON PLC-ADR

NYSE:HLN (1/17/2025, 8:06:14 PM)

After market: 9.14 -0.1 (-1.08%)

9.24

+0.05 (+0.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)N/A N/A
Inst Owners43.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap41.78B
Analysts79.2
Price Target10.38 (12.34%)
Short Float %0.45%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.94%
Min EPS beat(2)2.34%
Max EPS beat(2)7.54%
EPS beat(4)3
Avg EPS beat(4)-3.99%
Min EPS beat(4)-31.84%
Max EPS beat(4)7.54%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.93%
Max Revenue beat(2)-2.49%
Revenue beat(4)0
Avg Revenue beat(4)-3.13%
Min Revenue beat(4)-4.51%
Max Revenue beat(4)-2.49%
Revenue beat(8)1
Avg Revenue beat(8)-2.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.05%
PT rev (3m)-3.43%
EPS NQ rev (1m)-60.12%
EPS NQ rev (3m)-64.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-60.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.74%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.16%
Valuation
Industry RankSector Rank
PE 54.35
Fwd PE 46.89
P/S 3.04
P/FCF 18.14
P/OCF 15.63
P/B 2.06
P/tB N/A
EV/EBITDA 15.75
EPS(TTM)0.17
EY1.84%
EPS(NY)0.2
Fwd EY2.13%
FCF(TTM)0.51
FCFY5.51%
OCF(TTM)0.59
OCFY6.4%
SpS3.04
BVpS4.48
TBVpS-2.63
PEG (NY)6.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.26%
ROE 6.55%
ROCE 8.57%
ROIC 5.87%
ROICexc 5.99%
ROICexgc 177.08%
OM 21.13%
PM (TTM) 9.66%
GM 61.56%
FCFM 16.78%
ROA(3y)3.39%
ROA(5y)3.07%
ROE(3y)6.03%
ROE(5y)4.97%
ROIC(3y)5.38%
ROIC(5y)4.91%
ROICexc(3y)5.51%
ROICexc(5y)5%
ROICexgc(3y)81.8%
ROICexgc(5y)65.41%
ROCE(3y)7.94%
ROCE(5y)7.24%
ROICexcg growth 3Y29.07%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.66%
ROICexc growth 5YN/A
OM growth 3Y0.01%
OM growth 5YN/A
PM growth 3Y-7.1%
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.69
Debt/EBITDA 2.77
Cap/Depr 98.06%
Cap/Sales 2.7%
Interest Coverage 5.98
Cash Conversion 81.55%
Profit Quality 173.62%
Current Ratio 0.84
Quick Ratio 0.58
Altman-Z 2.45
F-Score6
WACC7.65%
ROIC/WACC0.77
Cap/Depr(3y)111.41%
Cap/Depr(5y)106.39%
Cap/Sales(3y)3.04%
Cap/Sales(5y)3.04%
Profit Quality(3y)135.99%
Profit Quality(5y)117.19%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.24%
EPS 3Y-1.91%
EPS 5YN/A
EPS Q2Q%-8.8%
EPS Next Y8.62%
EPS Next 2Y8.84%
EPS Next 3Y8.88%
EPS Next 5Y8.34%
Revenue 1Y (TTM)-0.65%
Revenue growth 3Y4.54%
Revenue growth 5YN/A
Sales Q2Q%-0.64%
Revenue Next Year-0.41%
Revenue Next 2Y1%
Revenue Next 3Y2.25%
Revenue Next 5Y4.27%
EBIT growth 1Y-0.38%
EBIT growth 3Y4.56%
EBIT growth 5YN/A
EBIT Next Year12.55%
EBIT Next 3Y7.26%
EBIT Next 5Y7.58%
FCF growth 1Y1.67%
FCF growth 3Y17.44%
FCF growth 5YN/A
OCF growth 1Y1.79%
OCF growth 3Y14.28%
OCF growth 5YN/A